1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Drug Delivery Insight 03 NOVEMBER 2014

Drug Delivery Insight 03 NOVEMBER 2014

  • November 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - BDSI Targets Further Opioid-Dependence Market Penetration With Long-Lasting Injectable
Industry Trend Analysis - Celgene Invests In Future With USD1bn Sutro Deal
Industry Trend Analysis - Ventana Secures Further Companion Diagnostic Partnership
Industry Brief - Portal Instruments Raises USD11mn To Develop Needle-Free Drug-Delivery Platform
Industry Brief - Horizon Acquires US Rights To Pennsaid 2% From Nuvo
Industry Brief - Alexza/Ferrer Expand Partnership For Adasuve
Industry Brief - pSivida Earns Iluvien Milestone Payment
Industry Brief - Takeda Exercises Option For Novel Fleximer ADC
Industry Brief - CSL/Enable Injections Enter Pact For Developing Novel Drug-Delivery System
Industry Brief - Zogenix/Purdue Exchange Waivers Of Regulatory Exclusivity For Hydrocodone Products
Industry Trend Analysis - Pfizer's Embeda Taps Into Growing Need For Abuse-Deterrent Opioids
Industry Brief - Sedasys CAPS System Launched In US
Industry Trend Analysis - Nanobiotix' NBTXR3 To Make The Unresectable Resectable
Industry Trend Analysis - Overwhelming COPD Market Will Dent Sunovion's Ambitions
Industry Trend Analysis - Aripiprazole Lauroxil Has Potential To Fuel Future Growth For Alkermes
Industry Brief - Capricor To Acquire Natriuretic Peptide Patent Rights
Industry Brief - Nanobiotix Earns Second Milestone Payment From Bpifrance For NBTXR3 Development
Industry Brief - Medtronic Initiates IDE Study Of Predictive Low Glucose Management Technology
Industry Brief - Discovery Labs/Battelle Collaborate On Aerosurf RDS Programme
Industry Brief - Anoro Ellipta Improved Lung Function Compared With Tiotropium
Industry Brief - Boston Scientific Initiates Promus Premier Stent Study In Underserved Patients
Industry Brief - Tekmira Commences Manufacture Of New RNA Therapeutic For Ebola-Guinea
Industry Brief - InMed Enters Collaboration For Proprietary Drug-Delivery System
Industry Brief - Immunomedics' Isactuzumab Govitecan Gains ODD In Europe For PC
Industry Brief - Spiriva HandiHaler/Striverdi Respimat Co-Administration Improves Lung Function In COPD Patients
Industry Brief - Phase III Results Published From AVP-825 Acute Migraine Study
Industry Brief - Drug Delivery Conferences - November 2014

Table Of Contents

Drug Delivery Insight 03 NOVEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the UK

  • January 2017
    19 pages
  • Therapy  

  • United Kingdom  

View report >

Biological Therapy Industry in the US

  • January 2017
    9 pages
  • Vaccine  

  • United States  

View report >

Global Therapy Market

  • January 2017
    32 pages
  • Therapy  

    Targeted Therap...  

    Monoclonal Anti...  

  • World  

View report >

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.